Category Archives: Vioxx

Featured Stories
Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

Fracking Should be Kept 600m From Aquifers, Study Says

New research on the safety of hydraulic fracturing (fracking) suggests new wells should not be dug within 600 meters of a water aquifer because underground fractures can extend about that far from a dug well. According to a report from UK’s The Guardian newspaper, researchers and geologists at Durham University have ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Google Searches Could Help FDA Identify Drug Side Effects

Google Searches Could Help FDA Identify Drug Side Effects

The Food and Drug Administration (FDA) has asked for Google’s help in identifying previously unknown side effects of medications. Last month, in a conference call, FDA officials spoke with a senior Google researcher who co-authored a 2013 paper about using search query … Continue reading

Posted in Health Concerns, Pharmaceuticals, Vioxx | Tagged , , , , |

Mis-marketing of Drugs Cost Billions, Endangers Health

Mis-marketing of Drugs Cost Billions, Endangers Health

A new report from the Center for Economic and Policy Research (CEPR) describes the high costs associated with the mis-marketing of prescription drugs, both in dollars and in health consequences. Spending on prescription drugs has consistently been the fastest growing … Continue reading

Posted in Avandia, Defective Products, Health Concerns, Pharmaceuticals, Vioxx | Tagged , , , , |

Vioxx Off-Label Marketing To Cost Merck $321 Million

Vioxx off-label marketing activities are going to cost Merck & Co. a whopping $321 million in criminal fines. The U.S. Food & Drug Administration (FDA) approved Vioxx (rofecoxib), a painkiller, for three indications in May 1999. Merck has pleaded guilty … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx | Tagged |

Vioxx Caused Complications Months After Patients Dropped It

< "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (Generic: rofecoxib), Merck’s blockbuster painkiller, might be responsible for blood clots in patients after they stopped taking it, write U.S. researchers, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a bestseller for Merck, with annual … Continue reading

Posted in Pharmaceuticals, Vioxx |

Supreme Court Gives Go Ahead to Vioxx Investor Lawsuit

Yesterday, the U.S. Supreme Court gave the go-ahead for a securities fraud lawsuit against pharmaceutical giant, Merck & Co Inc., over its disclosures to investors about < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a … Continue reading

Posted in Class Action Lawsuits, Health Concerns, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Settlement Almost Wrapped Up

Merck & Co. has made a final $4.1 billion payment to its < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx settlement fund. According to an Associated Press report, final payouts to former Vioxx users or their survivors should be made by the end of June. Vioxx … Continue reading

Posted in Pharmaceuticals, Vioxx |

Doctor Accused of Falsifying Drug Studies Pleads Guilty

Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health care fraud. As we’ve reported previously, Reuben was charged in federal court last month with … Continue reading

Posted in Pharmaceuticals, Vioxx |

Vioxx Scandal Didn’t Lead To Changes At FDA

The < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx scandal, and the Food & Drug Administration’s (FDA) role in it, has not brought about much change at the agency, according to a new government report. Vioxx was approved for use in 1999, and quickly became a … Continue reading

Posted in Pharmaceuticals, Vioxx |

Vioxx Shareholder Lawsuit Before US Supreme Court

Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx |

Vioxx Dangers Should Have Been Known Years Before Recall

We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have … Continue reading

Posted in Pharmaceuticals, Vioxx |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.